P&G Q1 Earnings Beat Prompts Wave of Analyst Price-Target Hikes

A volume-led beat, and Wall Street responds

Procter & Gamble started fiscal 2027 with the kind of quarter its bulls had been waiting for, and analysts moved quickly to raise their targets on the stock. For the July–September period, the consumer-goods company reported net sales of $23.3 billion, up 4% from a year earlier. Organic sales, which strip out currency moves and acquisitions, also grew 4%.11 Core earnings per share came in at $2.00, up 1%, and diluted EPS was $1.97.11

Both numbers beat expectations. CNBC, citing LSEG's survey of analysts, put the consensus at $1.88 in adjusted EPS on $22.8 billion in revenue.12 Investing.com had a slightly higher EPS consensus of $1.89 against $22.82 billion in revenue,16 and MarketBeat also used the $1.89 figure.2 Whichever baseline you pick, P&G cleared it by more than ten cents a share and by about half a billion dollars in sales.

One early headline got the result backwards. A GuruFocus story said EPS "misses" at $1.97, yet in the body it put the analyst estimate at $1.84, which would make $1.97 a beat as well.19 Every other outlet reported that P&G topped forecasts on both lines, and that is the right reading.1216

Analysts raise targets

On the day after the report, a string of brokerages raised their price targets. According to a roundup that drew on The Fly, Morgan Stanley went to $185 from $166, Wells Fargo to $180 from $164, JPMorgan to $180 from $162, Deutsche Bank to $176 from $162, Citi to $187 from $180, RBC Capital to $169 from $166, and Goldman Sachs to $161 from $150.1 Separate rating updates showed UBS at $190, up from $172,10 BNP Paribas at $189, up from $177,7 and Evercore ISI at $180, up from $166.6 TD Cowen also lifted its target, to $166 from $150, but kept a hold rating.2

The reasons the bulls gave were consistent. Deutsche Bank called the quarter the "clearest evidence yet" that P&G's work on categories and customers, its innovation and its push to restore product superiority were improving underlying performance.1 Morgan Stanley said brand interventions and reinvestment had "begun to bear fruit" and saw P&G as well placed on relative EPS in a difficult household-and-personal-care environment.1 RBC's Nik Modi pointed to organic growth in every category, solid underlying results once one-time items were removed, continued market-share recovery, and the levers P&G has to manage high costs.1 Wells Fargo noted that this was P&G's strongest organic growth in nearly three years and that easier comparisons are coming in the second and fourth quarters. In its view, that puts upside to the reiterated sales guidance "well in scope."1

Not everyone moved into the bull camp. Goldman stayed at Neutral, and its new $161 target was roughly where the stock was trading on Friday morning.5 TD Cowen's $166 target implied almost no upside from the $165.94 opening price.2 Overall ratings stay split: Koyfin data show 13 of 25 covering analysts at Buy or Strong Buy and 12 at Hold,1 while MarketBeat counts 14 Buys and 10 Holds and a consensus target of $164.25.2 Many of the higher targets haven't yet worked their way into the consensus figure.

What drove the quarter

The main reason analysts reacted so strongly is how the growth was made up. Volume added 2.4 percentage points of organic growth, product mix 1.1 points and pricing only 0.4 points.1516 For a company that relied heavily on price increases in recent years, growth led by people buying more is a better sign of health.

The gains were broad. All 10 product categories and all six geographic regions grew organically.1617 Organic sales rose 5% in Beauty, 5% in Grooming, 5% in Fabric & Home Care, 3% in Health Care and 3% in Baby, Feminine & Family Care.11 Fabric & Home Care, which includes Tide and Febreze, was the standout, with volume up 4.3% as demand for laundry detergent and fabric enhancers improved.1216 By region, Greater China grew 8%, the enterprise markets 5%, Europe 4% and North America 3%.18 Management said the China gains were led by SK-II and by Pampers, which it said benefited from "near-term competitive dynamics," so some of that strength may not last.1820

The change from the prior quarter is large. Organic growth was 0.5% in the fourth quarter of fiscal 2026 and 4.0% in this one.16 In the U.S., management said more than 70% of its leading customers held or gained share, compared with under 10% in the first half of fiscal 2026 and 50% in the second half. It is aiming for more than 80% by the end of the calendar year.18

Margins tell a different story

Below the sales line, the picture is less encouraging. Reported net earnings attributable to P&G slipped to $4.73 billion from $4.75 billion.12 Core gross margin fell 150 basis points and core operating margin fell 80 basis points, to 25.9%.1120 Currency-neutral core EPS was flat on the year.11 Productivity savings of 250 basis points helped but did not fully offset higher costs for raw materials, energy and freight, plus increased spending on marketing and promotion.1617

The quarter also had some help that won't repeat. Management cited roughly $90 million from the second part of a tariff refund and said only part of the commodity-cost increase had shown up yet.18 That is why RBC focused on underlying results excluding one-time factors.1 It also means the clean 4% sales growth gives a better view of the business than the 1% EPS gain does.

The cost outlook got worse. P&G raised its estimate of after-tax commodity headwinds for the year to about $1.4 billion, up from $1.0 billion.16 That assumes Brent crude at $100 a barrel for the rest of the fiscal year.20 MarketBeat's summary of the call puts the total after-tax headwind at about $1.9 billion once foreign exchange, higher interest expense and lower non-operating income are added.17 Net interest expense alone is expected to rise by about $300 million after tax, largely because of debt taken on for recent acquisitions.20

Guidance: unchanged, with a footnote

P&G kept its fiscal 2027 targets: organic sales growth of 1% to 3% and core EPS growth of flat to 3%, or $6.89 to $7.11 a share.1317 The one change was to all-in sales growth, now 2% to 4% instead of 1% to 3%. That reflects the acquisition of supplements brand Thorne, which closed October 1, rather than any change in the core business.12 Reports that P&G "boosted" its sales outlook should be read with that in mind.2 Management expects about 3% organic growth in the first half, a slight pickup in the second half, and continued volatility from quarter to quarter.18

Shareholder returns stay large. P&G returned $3.9 billion in the quarter, $2.6 billion in dividends and $1.3 billion in buybacks.11 It plans about $15 billion for the full year: more than $10 billion in dividends and about $5 billion in repurchases.17

The stock: rally, then a pause

The shares responded quickly. The Motley Fool's transcript page showed PG up 5.86% on results day,20 and MarketBeat said the stock hit a new 52-week high as investors favored defensive names while large caps weakened.2 On Friday, even as the target increases came in, the stock fell back. It was down 1.6% in one report1 and at $161.28 by mid-morning, about 3.6% below its 52-week high of $167.25.5

Our read

The higher targets are justified by what they are based on. Growth across every category and region, driven mainly by volume, is better evidence of a turnaround than earlier quarters that leaned on price increases. Easier comparisons ahead give the bulls a reasonable case for beating the sales guidance.1 But leaving EPS guidance unchanged while raising the cost forecast by $400 million means P&G is essentially promising to offset higher costs, not to grow earnings faster.16 Friday's pullback suggests investors are already weighing those two things. Over the next few quarters, the key question is whether the 250 basis points of productivity savings and the volume gains can hold margins steady once the full commodity increase arrives. Sales growth alone won't settle that.